A Single-blind, Randomized, Placebo-controlled, Single-centre Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics after 7 Days Repeated Administration of Escalating Oral Doses of AZD3355 solution in Healthy Japanese Male Subjects
Study identifier:D9120C00025
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Single-blind, Randomized, Placebo-controlled, Single-centre Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics after 7 Days Repeated Administration of Escalating Oral Doses of AZD3355 solution in Healthy Japanese Male Subjects
Medical condition
unknown
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 2008
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
